Moderately High Oxalate (MOx) Diet for Enteric Hyperoxaluria

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Enteric HyperoxaluriaModerately High Oxalate (MOx) Diet - Other
Eligibility
18 - 80
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test the effects of a high oxalate diet on subjects with IBD or who have had gastric bypass surgery.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 5 Secondary · Reporting Duration: Day 23-24

Day 23-24
Calcium Oxalate (CaOx) Supersaturation Levels
Plasma Oxalate Levels
Sucralose Levels
Total Fecal Oxalate Levels
Urinary Calcium Levels
Urinary Oxalate Levels (UOx)

Trial Safety

Trial Design

2 Treatment Groups

Healthy Controls
1 of 2
Enteric Hyperoxaluria
1 of 2

Active Control

Experimental Treatment

80 Total Participants · 2 Treatment Groups

Primary Treatment: Moderately High Oxalate (MOx) Diet · No Placebo Group · N/A

Enteric Hyperoxaluria
Other
Experimental Group · 1 Intervention: Moderately High Oxalate (MOx) Diet · Intervention Types: Other
Healthy Controls
Other
ActiveComparator Group · 1 Intervention: Moderately High Oxalate (MOx) Diet · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: day 23-24

Who is running the clinical trial?

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,148 Previous Clinical Trials
4,074,707 Total Patients Enrolled
1 Trials studying Enteric Hyperoxaluria
114 Patients Enrolled for Enteric Hyperoxaluria
NYU Langone HealthLead Sponsor
1,264 Previous Clinical Trials
753,511 Total Patients Enrolled
David Goldfarb, MDPrincipal InvestigatorNYU Langone Health
8 Previous Clinical Trials
1,192 Total Patients Enrolled
Lama Nazzal, MDStudy ChairNYU Langone Health

Eligibility Criteria

Age 18 - 80 · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
We will include all racial and ethnic groups, and both men and women.